Lung Forum 2024-2025


Now accepting applications through April 10th.
Selected applicants notified by April 15th.


Up to 25 applicants will be selected to participate in the Next Wave Forum.

  • Applicants must be in their final two years of a fellowship program OR within five years post-fellowship
  • Applicants must be US- or Canada-based (MDs, MD/PhDs, or DOs) and currently employed in active patient care and patient-oriented clinical research, or being trained at an institution in the US or Canada. Applicants must not be employed by a commercial pharmaceutical, biotech, or other biomedical company
  • Selected applicants must commit to actively participating in the program for the full year of activities


  • Individuals residing or working outside of the US or Canada at the time of application are not eligible
  • Individuals who have received independent research funding at the time of application are not eligible
  • PhD-only research fellows are not eligible

Application Components

Applicants must complete the online application by providing all of the following materials:

Letter of recommendation or support from fellowship program director or clinical investigator in the field of thoracic oncology

NIH Biosketch (preferred; maximum 5 pages) or CV

Brief video (2 minutes or less) explaining why they want to participate in the Next Wave Forum, demonstrating the applicants' presentation skills and detailing their goals for the one-year program

Submission of an abstract for the conference (may be a summary of a research plan for a future study)

Selection Process

The Next Wave faculty will review all applications. Applicants will be evaluated on the following criteria:

Contribution to Science

Clear commitment to an academic oncology career through publication and research efforts, and training to date

Clear Goals

Specific and achievable aims for the mentoring program

Abstract Quality

Submitted abstracts will be evaluated using the following criteria:

  • Scientific importance: Will this research make a difference in diagnosis, treatment, or quality of patient care?
  • Quality of research: Is the hypothesis feasible and will the stated methodology enable this research to be completed in a meaningful way?
  • Enhancement of knowledge: Will the research improve our knowledge about the disease of treatment?
  • Does the research answer a question that needs to be answered or provide new findings that may change the way we diagnose or treat lung cancer?
  • Overall presentation of abstract: Is the abstract informative and thoughtfully written? Does it outline the question to be addressed? Is the research proposed able to provide an answer?